LGVN
LGVN
NASDAQ · Biotechnology

Longeveron Inc-A

$0.92
-0.05 (-5.44%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,909.8% upside
Low Target $21.92
Average Target $27.69
High Target $40.08
Current Price $0.92
Current
$0.92
Target
$27.69
$21.92 $27.69 avg $40.08
Scenario Analysis
Bear Case
$21.92
2,282.6%
Low target
Base Case
$27.69
+2,909.8%
Avg target
Bull Case
$40.08
+4,256.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.83
-49.7% from high
52-Week Low
$0.48
+93.7% from low
Target vs 52W High
$27.69
+1,413.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%